These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7837245)

  • 1. Potent non-peptide fibrinogen receptor antagonists which present an alternative pharmacophore.
    Ku TW; Miller WH; Bondinell WE; Erhard KF; Keenan RM; Nichols AJ; Peishoff CE; Samanen JM; Wong AS; Huffman WF
    J Med Chem; 1995 Jan; 38(1):9-12. PubMed ID: 7837245
    [No Abstract]   [Full Text] [Related]  

  • 2. Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist.
    Bondinell WE; Keenan RM; Miller WH; Ali FE; Allen AC; de Brosse CW; Eggleston DS; Erhard KF; Haltiwanger RC; Huffman WF
    Bioorg Med Chem; 1994 Sep; 2(9):897-908. PubMed ID: 7712125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
    Müller G; Gurrath M; Kessler H
    J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J; Ali F; Romoff T; Calvo R; Sorenson E; Vasko J; Storer B; Berry D; Bennett D; Strohsacker M
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
    O'Neil KT; Hoess RH; Jackson SA; Ramachandran NS; Mousa SA; DeGrado WF
    Proteins; 1992 Dec; 14(4):509-15. PubMed ID: 1438188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of a C7 mimetic for the predicted gamma-turn conformation found in several constrained RGD antagonists.
    Callahan JF; Bean JW; Burgess JL; Eggleston DS; Hwang SM; Kopple KD; Koster PF; Nichols A; Peishoff CE; Samanen JM
    J Med Chem; 1992 Oct; 35(21):3970-2. PubMed ID: 1433204
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp.
    Egbertson MS; Chang CT; Duggan ME; Gould RJ; Halczenko W; Hartman GD; Laswell WL; Lynch JJ; Lynch RJ; Manno PD
    J Med Chem; 1994 Aug; 37(16):2537-51. PubMed ID: 8057299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Asp-carboxylate of RGDX mimetics and the platelet GP IIb-IIIa receptor.
    Zablocki JA; Miyano M; Rao SN; Panzer-Knodle S; Nicholson N; Feigen L
    J Med Chem; 1992 Dec; 35(26):4914-7. PubMed ID: 1479591
    [No Abstract]   [Full Text] [Related]  

  • 10. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.
    Blackburn BK; Lee A; Baier M; Kohl B; Olivero AG; Matamoros R; Robarge KD; McDowell RS
    J Med Chem; 1997 Feb; 40(5):717-29. PubMed ID: 9057858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
    Hartman GD; Egbertson MS; Halczenko W; Laswell WL; Duggan ME; Smith RL; Naylor AM; Manno PD; Lynch RJ; Zhang G
    J Med Chem; 1992 Nov; 35(24):4640-2. PubMed ID: 1469694
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of fibrinogen binding to platelets by MK-852, a new GPIIb/IIIa antagonist.
    Larsson A; Lindahl TL
    Ups J Med Sci; 1994; 99(2):121-9. PubMed ID: 7716823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa.
    Gartner TK; Loudon R; Taylor DB
    Biochem Biophys Res Commun; 1991 Nov; 180(3):1446-52. PubMed ID: 1953789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional aspects of RGD-containing protein antagonists of glycoprotein IIb-IIIa.
    Lazarus RA; McDowell RS
    Curr Opin Biotechnol; 1993 Aug; 4(4):438-45. PubMed ID: 7763974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of 1,4-benzodiazepine cholecystokinin type B antagonists.
    Bock MG; DiPardo RM; Evans BE; Rittle KE; Whitter WL; Garsky VM; Gilbert KF; Leighton JL; Carson KL; Mellin EC
    J Med Chem; 1993 Dec; 36(26):4276-92. PubMed ID: 8277510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mambin, a potent glycoprotein IIb-IIIa antagonist and platelet aggregation inhibitor structurally related to the short neurotoxins.
    McDowell RS; Dennis MS; Louie A; Shuster M; Mulkerrin MG; Lazarus RA
    Biochemistry; 1992 May; 31(20):4766-72. PubMed ID: 1591238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists.
    Kerwin JF; Nadzan AM; Kopecka H; Lin CW; Miller T; Witte D; Burt S
    J Med Chem; 1989 Apr; 32(4):739-42. PubMed ID: 2704023
    [No Abstract]   [Full Text] [Related]  

  • 18. Low molecular weight, non-peptide fibrinogen receptor antagonists.
    Alig L; Edenhofer A; Hadváry P; Hürzeler M; Knopp D; Müller M; Steiner B; Trzeciak A; Weller T
    J Med Chem; 1992 Nov; 35(23):4393-407. PubMed ID: 1447740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
    Barker PL; Bullens S; Bunting S; Burdick DJ; Chan KS; Deisher T; Eigenbrot C; Gadek TR; Gantzos R; Lipari MT
    J Med Chem; 1992 May; 35(11):2040-8. PubMed ID: 1597855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonist.
    Duggan ME; Naylor-Olsen AM; Perkins JJ; Anderson PS; Chang CT; Cook JJ; Gould RJ; Ihle NC; Hartman GD; Lynch JJ
    J Med Chem; 1995 Aug; 38(17):3332-41. PubMed ID: 7650686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.